Related Experiment Video
Updated: Jan 25, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD
Anabel Sorolla1, Edina Wang1, Tristan D Clemons2
1Cancer Epigenetics, Harry Perkins Institute of Medical Research Nedlands, WA 6009, Australia; School of Human Sciences, The University of Western Australia Crawley, WA 6009, Australia.
Abstract:
Triple negative breast cancers (TNBC) are aggressive malignancies for which chemotherapy is the only treatment option. Many TNBC acquire chemotherapy resistance, notably docetaxel, which has been associated with the overexpression of transcription factors (TFs), such as ENGRAILED1 (EN1). Here, we have developed a tumor delivery system for docetaxel-PGMA-PAA-nanoparticles and interference peptides designed to specifically inhibit EN1 (EN1-iPeps). To promote tumor specific targeting, we functionalized these nanoparticles with EN1-iPeps engineered with RGD sequences. We found that these peptides reduce cell viability and induce apoptosis in TNBC cells with negligible effects on normal cells (EN1-). Moreover, EN1-RGD-iPeps-mediated nanoparticle internalization into breast cancer cells was via integrins and intravenous injection of this nanoformulation increased tumor accumulation. Furthermore, docetaxel nanoparticles functionalized with EN1-RGD-iPeps significantly reduced TNBC growth both in vitro and in vivo without showing toxicity. Our results suggest that this targeted nanoformulation represents a new and safe therapeutic approach for chemoresistant TNBCs.
Insights
This study introduces novel nanoparticles targeting chemotherapy-resistant triple-negative breast cancer (TNBC). The targeted delivery system effectively reduces tumor growth and induces apoptosis with minimal toxicity, offering a promising new therapeutic strategy.
Area of Science:
- Oncology
- Nanotechnology
- Molecular Biology
Background:
- Triple-negative breast cancer (TNBC) is aggressive and often develops resistance to chemotherapy, including docetaxel.
- Overexpression of transcription factor ENGRAILED1 (EN1) is linked to docetaxel resistance in TNBC.
Purpose of the Study:
- To develop and evaluate a targeted nanoformulation for docetaxel delivery to chemoresistant TNBC.
- To investigate the efficacy of inhibiting EN1 using interference peptides (EN1-iPeps) conjugated to nanoparticles.
Main Methods:
- Development of docetaxel-loaded nanoparticles functionalized with EN1-inhibiting peptides (EN1-iPeps) and RGD sequences for enhanced tumor targeting.
- Assessment of EN1-RGD-iPeps' effect on TNBC cell viability and apoptosis in vitro.
- Evaluation of nanoparticle internalization via integrins and tumor accumulation after intravenous injection.
- In vitro and in vivo assessment of the nanoformulation's efficacy in reducing TNBC growth and toxicity.
Main Results:
- EN1-RGD-iPeps reduced TNBC cell viability and induced apoptosis with minimal impact on normal cells.
- Nanoparticle uptake in breast cancer cells was mediated by integrins, and intravenous administration increased tumor accumulation.
- The docetaxel-loaded nanoparticles functionalized with EN1-RGD-iPeps significantly inhibited TNBC growth in vitro and in vivo.
- The nanoformulation demonstrated no significant toxicity.
Conclusions:
- Targeted inhibition of EN1 using RGD-functionalized nanoparticles offers a novel therapeutic strategy for chemoresistant TNBC.
- This nanoformulation shows potential as a safe and effective treatment for TNBC by overcoming chemotherapy resistance.
Related Concept Videos
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....
Peptide Bonds
Negative Regulator Molecules
Positive, Negative, and Zero Work
Therapeutic Index
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...

